ArticleExploratory research in clinical and social pharmacy2026
Association between functional assertiveness and stress related to deprescribing recommendations among community pharmacists: A cross-sectional study.
Article in Exploratory research in clinical and social pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Polypharmacy is an important challenge in an aging society, and pharmacists recommending deprescribing is beneficial from a patient safety perspective. However, this process often creates interprofessional communication challenges between pharmacists and physicians, leading to stress for community pharmacists. Assertiveness, defined as expressing oneself openly while respecting others, is an educable skill for managing work-related stress in healthcare settings and is considered a stress-coping factor. However, its specific effect on the stress related to deprescribing remains unclear. Objective: This study aimed to investigate stress levels related to deprescribing recommendations among community pharmacists and examine their relationship with the level of assertiveness. Methods: A cross-sectional survey was conducted among community pharmacists between May and October 2022. Participants were community pharmacists belonging to two pharmacy chains in Japan. The primary outcome variable was stress related to deprescribing recommendations, which was used to categorize respondents into high-stress (Visual Analog Scale [VAS] ≥ 70) and low-stress (VAS < 70) groups. The primary explanatory variable was the Functional Assertiveness Scale (FAS) total score, and respondents were dichotomized based on the median score. Pharmacist characteristics were compared by stress group in univariate analyses. A Generalized Linear Model with a binomial distribution was used to examine the association between FAS score and the likelihood of low stress, adjusting for confounding factors including demographics and organizational variables. Results: A total of 415 pharmacists were included in the final analysis and 40.2% were classified into the high-stress group. In the adjusted multivariate model, high functional assertiveness was significantly positive associated with reporting low stress (odds ratio, 2.62; 95% confidence interval, 1.66-4.14; Conclusion: Higher functional assertiveness among community pharmacists is associated with lower stress related to recommending deprescribing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.